Eric Crombez

1.1k total citations
30 papers, 856 citations indexed

About

Eric Crombez is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Eric Crombez has authored 30 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Physiology and 9 papers in Clinical Biochemistry. Recurrent topics in Eric Crombez's work include Lysosomal Storage Disorders Research (13 papers), Metabolism and Genetic Disorders (9 papers) and Carbohydrate Chemistry and Synthesis (6 papers). Eric Crombez is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Metabolism and Genetic Disorders (9 papers) and Carbohydrate Chemistry and Synthesis (6 papers). Eric Crombez collaborates with scholars based in United States, United Kingdom and Spain. Eric Crombez's co-authors include Stephen D. Cederbaum, Ari Zimran, Nicola Longo, Deborah Elstein, Alex Dorenbaum, Judith D. Bebchuk, Jon A. Wolff, Heidi Christ‐Schmidt, Barbara K. Burton and Paul Harmatz and has published in prestigious journals such as Blood, The Journal of Pediatrics and Genomics.

In The Last Decade

Eric Crombez

28 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Crombez United States	17	457	448	415	140	122	30	856
Ricardo Flores Pires Brazil	15	286 0.6×	338 0.8×	251 0.6×	94 0.7×	43 0.4×	36	624
Annette S. Feigenbaum Canada	11	374 0.8×	257 0.6×	387 0.9×	36 0.3×	73 0.6×	13	620
Ángela Arias Spain	18	290 0.6×	146 0.3×	278 0.7×	237 1.7×	51 0.4×	31	673
N. Chamoles Argentina	11	302 0.7×	120 0.3×	230 0.6×	76 0.5×	62 0.5×	20	498
Mercedes Martínez‐Pardo Spain	16	559 1.2×	191 0.4×	589 1.4×	55 0.4×	85 0.7×	35	782
Bing-Zhi Yang United States	13	232 0.5×	160 0.4×	159 0.4×	39 0.3×	38 0.3×	18	445
María Teresa García‐Silva Spain	12	392 0.9×	83 0.2×	234 0.6×	82 0.6×	35 0.3×	24	595
Johann Penzien Germany	14	268 0.6×	76 0.2×	184 0.4×	33 0.2×	69 0.6×	17	627
Vibeke Winter Denmark	18	977 2.1×	204 0.5×	990 2.4×	108 0.8×	157 1.3×	28	1.3k
M.T. García‐Silva Spain	10	378 0.8×	86 0.2×	170 0.4×	51 0.4×	18 0.1×	16	515

Countries citing papers authored by Eric Crombez

Since Specialization

Citations

This map shows the geographic impact of Eric Crombez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Crombez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Crombez more than expected).

Fields of papers citing papers by Eric Crombez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Crombez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Crombez. The network helps show where Eric Crombez may publish in the future.

Co-authorship network of co-authors of Eric Crombez

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Crombez. A scholar is included among the top collaborators of Eric Crombez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Crombez. Eric Crombez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weinstein, David A., Terry G. J. Derks, David Rodriguez‐Buritica, et al.. (2025). Safety and Efficacy of DTX401 , an AAV8 ‐Mediated Liver‐Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a ( GSDIa ). Journal of Inherited Metabolic Disease. 48(2). e70014–e70014. 7 indexed citations

Harding, Cary O., Janet Thomas, María L. Couce, et al.. (2025). P171: Durable efficacy and safety of DTX301: Long-term follow up of a phase 1/2 trial in adults with ornithine transcarbamylase deficiency*. Genetics in Medicine Open. 3. 102136–102136. 2 indexed citations

Thomas, Janet, Wen‐Hann Tan, Aneal Khan, et al.. (2024). Long-term safety and efficacy of DTX301 in adults with late-onset ornithine transcarbamylase (OTC) deficiency: A Phase 1/2 trial. Molecular Genetics and Metabolism. 141(4). 108266–108266. 1 indexed citations

Rodriguez‐Buritica, David, Ayesha Ahmad, Terry G. J. Derks, et al.. (2022). COHORT 1-4 RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF AN AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA (GSDIA). Molecular Genetics and Metabolism. 135(4). 296–296.

Pipe, Steven W., Kimo C. Stine, Anita Rajasekhar, et al.. (2017). 101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX). Blood. 130. 3331–3331. 23 indexed citations

Eichler, Florian, Timothy M. Cox, Eric Crombez, Christine í Dali, & Alfried Kohlschütter. (2016). Metachromatic Leukodystrophy. Journal of Child Neurology. 31(13). 1457–1463. 26 indexed citations

Smith, Laurie D., William J. Rhead, Joel Charrow, et al.. (2015). Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase. Molecular Genetics and Metabolism. 117(2). 164–171. 26 indexed citations

Elstein, Deborah, Pilar Giraldo, Atul Mehta, et al.. (2014). Safety and efficacy of long-term enzyme replacement therapy with velaglucerase alfa in patients with type 1 Gaucher disease transitioned from imiglucerase. Molecular Genetics and Metabolism. 111(2). S41–S42.

Turkia, Hadhami Ben, Derlis Gonzalez, Norman W. Barton, et al.. (2012). Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease. American Journal of Hematology. 88(3). 179–184. 48 indexed citations

10.

Gonzalez, Derlis, Hadhami Ben Turkia, Elena Lukina, et al.. (2012). Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study. American Journal of Hematology. 88(3). 166–171. 62 indexed citations

11.

Zimran, Ari, Gregory M. Pastores, Anna Tylki‐Szymańska, et al.. (2012). Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase. American Journal of Hematology. 88(3). 172–178. 48 indexed citations

12.

Trefz, Friedrich K., Barbara K. Burton, Nicola Longo, et al.. (2009). Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Pediatrics. 154(5). 700–707.e1. 156 indexed citations

13.

Crombez, Eric, Stephen D. Cederbaum, Elaine Spector, et al.. (2008). Maternal glutaric acidemia, type I identified by newborn screening. Molecular Genetics and Metabolism. 94(1). 132–134. 30 indexed citations

14.

Lee, Phillip, Eileen P. Treacy, Eric Crombez, et al.. (2008). Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria. American Journal of Medical Genetics Part A. 146A(22). 2851–2859. 79 indexed citations

15.

Miousse, Isabelle R., David Watkins, David Coelho, et al.. (2008). Clinical and Molecular Heterogeneity in Patients with the CblD Inborn Error of Cobalamin Metabolism. The Journal of Pediatrics. 154(4). 551–556. 34 indexed citations

16.

Schimmenti, Lisa A., Eric Crombez, Bernd Schwahn, et al.. (2006). Expanded newborn screening identifies maternal primary carnitine deficiency. Molecular Genetics and Metabolism. 90(4). 441–445. 72 indexed citations

17.

Crombez, Eric, Richard Koch, & Stephen D. Cederbaum. (2005). Pitfalls in Newborn Screening. The Journal of Pediatrics. 147(1). 119–120. 2 indexed citations

18.

Crombez, Eric & Stephen D. Cederbaum. (2004). Hyperargininemia due to liver arginase deficiency. Molecular Genetics and Metabolism. 84(3). 243–251. 107 indexed citations

19.

Chiang, Pei-Wen, Woo‐Joo Song, Eric Crombez, et al.. (1996). Isolation and Characterization of the Human and Mouse Homologues (SUPT4H andSupt4h) of the Yeast SPT4 Gene. Genomics. 34(3). 368–375. 18 indexed citations

20.

Chiang, Pei-Wen, Grzegorz Dzida, Jan‐Fang Cheng, et al.. (1995). Expressed Sequence Tags from the Long Arm of Human Chromosome 21. Genomics. 29(2). 383–389. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact